Showing 22 results for Diabetes Mellitus
Sara Derakhshan, Fateme Ganjeh, Korosh Rezaei, Elaheh Noroozi ,
Volume 27, Issue 6 (1-2025)
Abstract
Introduction: Diabetic foot ulcer is the most common cause of hospitalization in diabetic people, while one of the prominent sources of anxiety in patients is the time of discharge from the hospital. This study aimed to determine the effect of the SMART discharge protocol on the anxiety of diabetic foot ulcer patients.
Methods: In this semi-experimental study, 50 patients with diabetic foot ulcers Were divided equally into two control (25 patients) and intervention (25 patients) groups, randomly and based on the Inclusion criteria. In the intervention group, the SMART discharge protocol was implemented from their admission to the day of discharge. The Demographic information questionnaire and Spielberger questionnaire were used to determine patients' anxiety. The data were analyzed at two descriptive and inferential levels.
Results: There was no statistically significant difference in the mean score of anxiety for diabetic foot ulcer patients in the two groups before the intervention. In contrast, after the intervention, the mean anxiety score in the two groups showed a statistically significant difference (P = 0.0001).
Conclusions: According to the results of the present study, it seems that the smart discharge protocol was effective in reducing the anxiety of diabetic foot ulcer patients. Therefore, it is recommended that nursing officials and managers implement this protocol.
Ebrahim Mohammadi, Laya Hooshmand, Arash Masumi,
Volume 28, Issue 1 (3-2025)
Abstract
Introduction: Novel antidiabetic medications are employed to manage glycemic control and mitigate the long-term complications of type 2 diabetes. This study aimed to investigate the prevalence of adverse events, including hypoglycemia, associated with these novel antidiabetic agents in a cohort of patients with type 2 diabetes.
Methods: This cross-sectional analytical study was conducted on 157 patients with type 2 diabetes mellitus attending the Endocrinology Clinic at Imam Khomeini Hospital, Urmia, during the summer of 2024. A convenience sampling method was employed to recruit participants. Data on demographics, the incidence of hypoglycemia, and reported adverse drug reactions were collected from all eligible patients through a structured interview. Subsequently, patients were stratified into three treatment groups based on the specific novel antidiabetic medication they received.
Results: In patients receiving sitagliptin, the most prevalent adverse events included arthralgia and rheumatic problems (26.31%), dermatological manifestations (36.84%), and allergic reactions (21.06%). Nausea (52.94%) and abdominal pain (17.65%) were the most frequent adverse events observed in patients treated with liraglutide. Polydipsia (28.72%), weakness and lethargy (26.6%), and dry mucous membranes (27.66%) were commonly reported in patients receiving empagliflozin. Hypoglycemia was observed predominantly in male patients aged 51-55 years receiving sitagliptin.
Conclusions: The findings of this study demonstrate a low incidence of hypoglycemia among patients treated with modern antidiabetic medications. Prevalent short-term adverse events observed included gastrointestinal disturbances, allergic reactions, and dermatological manifestations.
